Clinical Trial Update: Stroke With Transfusions Changing to Hydroxyurea [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating switching from chronic transfusions to hydroxyurea for stroke prevention in sickle cell disease was terminated; results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemochromatosis
• Sickle Cell Disease
• Stroke

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Hemochromatosis, Cerebrovascular Accident | Phase 3 | Status: TERMINATED | Results posted: 2012-08-17